Apollo Endosurgery, Inc.
APEN · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $301,525 | $225,071 | $147,313 | $239,896 |
| - Cash | $57,002 | $66,906 | $74,736 | $81,730 |
| + Debt | $57,065 | $54,092 | $53,817 | $53,735 |
| Enterprise Value | $301,588 | $212,257 | $126,394 | $211,901 |
| Revenue | $21,314 | $19,573 | $19,307 | $16,662 |
| % Growth | 8.9% | 1.4% | 15.9% | – |
| Gross Profit | $11,357 | $10,738 | $10,959 | $9,373 |
| % Margin | 53.3% | 54.9% | 56.8% | 56.3% |
| EBITDA | -$4,553 | -$9,350 | -$8,434 | -$6,264 |
| % Margin | -21.4% | -47.8% | -43.7% | -37.6% |
| Net Income | -$9,553 | -$11,446 | -$10,426 | -$8,414 |
| % Margin | -44.8% | -58.5% | -54% | -50.5% |
| EPS Diluted | -0.32 | -0.28 | -0.26 | -0.21 |
| % Growth | -14.3% | -7.7% | -23.8% | – |
| Operating Cash Flow | -$10,303 | -$6,196 | -$6,074 | -$8,689 |
| Capital Expenditures | -$512 | -$1,126 | -$556 | -$551 |
| Free Cash Flow | -$10,815 | -$7,322 | -$6,630 | -$9,240 |